FierceBiotech 2026年4月20日 FDA celebrates progress to end animal testing but experts warn there’s still a long way to go
FierceBiotech 2026年4月20日 AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs
FierceBiotech 2026年4月18日 AACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
FierceBiotech 2026年4月17日 UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine
FierceBiotech 2026年4月17日 Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
FierceBiotech 2026年4月17日 A new benchmark for biotech IPOs? Kailera raises $625M to fund obesity pipeline
FierceBiotech 2026年4月17日 Small pools, big ideas: How the rare disease community is reimagining clinical trials
FierceBiotech 2026年4月16日 RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
FierceBiotech 2026年4月16日 Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal
FierceBiotech 2026年4月16日 Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech 2026年4月16日 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again